The treatment of parapneumonic effusions and pleural empyemas;Die behandlung des parapneumonischen ergusses und des pleuraempyems

Pneumologie

Volumn 59, Issue 10, 2005, Pages 696-703

  Hamm, Hinrich ^a,b  

^a Rehabilitationsklinik für Atemwegs und Tumorerkrankungen der Asklepios Nordseeklinik ^*  (Germany)

^b Abt Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CLINDAMYCIN; DORNASE ALFA; FIBRINOLYTIC AGENT; LINEZOLID; MACROLIDE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTODORNASE PLUS STREPTOKINASE; STREPTOKINASE; UROKINASE;

ANTIBIOTIC THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FIBRINOLYTIC THERAPY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; PLEURA CAVITY; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SURGICAL DRAINAGE; THORACOSCOPY; THORACOTOMY; VIDEO ASSISTED THORACOSCOPY; VIDEORECORDING;

DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; PLEURAL CAVITY; PLEURAL EFFUSION;

EID: 27644568688     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870982     Document Type: Review

References (40)

1. Bülau G. Für die Heber-Drainage bei Behandlung des Empyems. Z klin Med 1891; 18: 31-45
2. Schede M. Die Behandlung der Empyeme. Verh Innere Med Wiesbaden 1890; 9: 41
3. Helfritzsch H, Lesser T, Seifert S et al. Stadiengerechte Therapie des Pleuraempyems. Ergebnisse im Zeitraum 1992 - 1998. Zentrabl Chir 2001; 125: 454-458
4. Frey DJ, Klapa J, Kaiser D. Spül-Drainage und Fibrinolyse zur Behandlung des metapneumonischen Pleuraempyems. Pneumologie 1999; 53: 596-604
5. Light RW. Pleural diseases. (4th ed.) Baltimore: Williams & Wilkins, 2001
6. Maskell NA, Davies RJ. Effusions from parapneumonic infection and empyema. In: Light RW and Lee (eds.): Textbook of pleural disease. London: Arnold, 2003
7. Hamm H. Pleural Effusions in the Immunocompromised Patient (including HIV). In: Light RW and YCG Lee: Textbook of pleural diseases. London: Arnold, 2003
8. Suay VG, Cordero PJ, Martinez E et al. Parapneumonic effusions secondary to community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients. Eur Respir J 1995; 8: 1934-1939
9. Miller RF, Foley NM, Kessel D et al. Community acquired lobar pneumonia in patients with HIV infection and AIDS. Thorax 1994; 49: 367-386
10. Ko SC, Chen KY, Hsueh PR et al. Fungal empyema thoracis: an emerging clinical entity. Chest 2000; 117: 1672-1680
11. Maskell NA, Davies CW, Jones E et al. The characteristics of 300 patients participating in the MRC/BTS multicentre intra-pleural streptokinase vs placebo trial. Am J Respir Crit Care Med 2002; 165: B11
12. Chen KY, Hsueh PR, Liaw YS et al. A 10-year experience with the bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000; 117: 1685-1689
13. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156
14. Colice GI, Curtis A, Deslauriers J et al. ACCP Consensus Statement: Medical and surgical treatment of parapneumonic effusions - an evidence-based guideline. Chest 2000; 118: 1158-1171
15. Maskell NA, Gleeson FV, Darby M et al. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest 2004; 126: 2022-2024
16. Hamm H, Fabel H. Chylothorax und Pseudochylothorax. Dtsch Med Wschr 1989; 114: 2017-2022
17. Sahn SA, Iseman MD. Tuberculous empyema. Semin Respir Infect 1999; 14: 82-87
18. Bouros D, Hamm H. Infectious pleural effusions. In: Pleural Diseases. Eur Respir Mon 2002; 22: 204-218
19. Vaudaux P, Waldvogel FA. Gentamicin inactivation in purulent exudates: the role of the cell lysis. J Infect Dis 1980; 142: 586-593
20. Loddenkemper R, Kaiser D, Frank W. Treatment of parapneumonic pleural effusion and empyema: conservative view. Eur Respir Mon 2004; 29: 199-207
21. Davies CWH, Gleeson FV, Davies RJO. BTS Guidelines for the management of pleural infection. Thorax 2003; 58: Suppl. 2: 18-28
22. Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest 1994; 105: 832-836
23. Tillett WS, Sherry S. Effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous exudations. J Clin Invest 1949; 28: 173-186
24. Bouros D, Schiza S, Patsourakis G et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions. Am J Respir Crit Care Med 1997; 155: 291-295
25. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111: 275-279
26. Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52: 416-421
27. Bouros D, Schiza S, Tzanakis N et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med 1999; 159: 37-42
28. Strange C, Allen ML, Harley R et al. Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis 1993; 147: 962-966
29. Diacon AH, Theron J, Schuurmans MM et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170: 49-53
30. Maskell NA, Davies RJ, Nunn AJ et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352: 865-874
31. Heffner JE. Multicenter trials of treatment for empyema - after all these years (Editorial). N Engl J Med 2005; 352: 926-928
32. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004; 2: CD002312
33. Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 2003; 58: 365-366
34. Wagner U, Vogelmeier C. Parapneumonischer Erguss und Pleuraempyem - Diagnostik und konservative Therapie. Dtsch Med Wochenschr 2005; 130: 525-529
35. Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir 1999; J13: 514-518
36. Wait MA, Sharma S, Hohn J et al. A randomized trial of empyema therapy. Chest 1997; 111: 1548-1551
37. Lauschke H, Decker P, Baldacci A et al. Erfahrungen in der stadiengerechten Therapie des Pleuraempyems. Zentralbl Chir 2001; 126: 696-701
38. Sendt W, Forster E, Hau T. Early thoracoscopic debridement and drainage as definitive treatment for pleural empyema. Eur J Surg 1995; 161: 73-76
39. Ridley PD, Braimbridge MV. Thoracoscopic debridement and pleural irrigation in the management of empyema thoracis. Ann Thorac Surg 1991; 51: 461-464
40. Martella AT, Santos GH. Decortication for chronic postpneumonic empyema. J Amer Coll Surgeons 1995; 180: 573-576